NIH Establishes Center for Research in Emerging Infectious Diseases –

NIH Establishes Center for Research in Emerging Infectious Diseases

News release

Thursday is August 27, 2020

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, announced today that it has made 11 grants to establish a research center in Emerging Infectious Diseases with a total first-year value of approximately $ 17 million. Huh. CREID). The global network will include a multi-disciplinary investigation of how and where viruses and other pathogens cause disease in people from wildlife and spillovers. NIAID intends to provide approximately $ 82 million over five years to support the network.

Anthony S., director of NIAID. Fauci said, “The impact of the COVID-19 pandemic serves as a strong reminder of the devastation that can occur when a new virus infects humans for the first time.” “The Creed Network will enable early warnings of emerging diseases wherever they occur, which will be important for rapid responses. The knowledge gained through this research will enhance our preparedness for future outbreaks. ”

Each center of the network will involve collaboration with peer institutions in the United States and 28 other countries. Research projects will include surveillance studies to identify previously unknown causes of febrile diseases in humans; Locate animal sources of viral or other disease-causing pathogens; And determine whether genetic or other changes enable these pathogens to infect humans. CREID investigators will develop reagents and diagnostic assays to improve detection of emerging pathogens and to study human immune responses to new or emerging infectious agents. Overall, the breadth of research projects in the CREID network will allow the study of disease outbreaks at several stages of the process: where pathogens first originate from an animal host; At the boundaries between wild and over-populated areas, where human-to-human transmission occurs; And, finally, in urban areas, where epidemics can spread.

Each center will focus efforts on one or more regions of the world. For example, in Central and South America, studies will involve the investigation of several arthropod-borne viruses (“arboviruses”), including zika virus disease, chikungunya, and dengue. In East and Central Africa, focus pathogens will include the Rift Valley fever virus and coronoviruses that cause Middle East respiratory syndrome. In West Africa, apart from arboviruses, the projects are slated on Ebola virus and Lassa virus. In Asia and Southeast Asia, investigators will conduct research on coronaviruses and arboviruses. In every field, investigators will be prepared to study any newly emerging pathogen known as “pathogen X.”

An award will be given to the RTI International in Research Triangle Park, North Carolina in collaboration with Duke University, Durham, North Carolina for the Creed Coordinating Center. The center will support activities such as network-management, data management, outbreak research response and quality control for biospeckins, assays and reagents. It will also manage a pilot research program for early career investigators.

For more information about CREID Network: go to

Coordination Center, 10 CREID, Principal Investigator, Center Name, Research Area and Grant Numbers are:

Donald Brambilla, PhD, RTI International, Research Triangle Park, North Carolina
Tony Moody, MD, Duke University School of Medicine, Durham, North Carolina
Composition coordination center; 1 U01AI151378-01

Christian Anderson, PhD, Scripps Research Institute, La Jolla, California
West African Emerging Infectious Disease Research Center (WAEIDRC)
West Africa; 1 U01 AI151812-01

Peter Daszak, PhD, Ecolitics Alliance, Inc., New York City
Emerging Infectious Diseases – South East Asia Research Cooperation Hub (EID-Discovery)
Southeast Asia; 1 U01 AI151797-01

Eva Harris, PhD, University of California, Berkeley
American and Asian Center for Arboviral Research and Augmented Surveillance (A2CARES)
Central and South America, South Asia; 1 U01 AI151788-01

Christine K. Johnson, VMD, PhD, University of California, Davis, School of Veterinary Medicine
Epicenter for Emerging Infectious Disease Intelligence (EEIDI)
Central Africa and South America; 1 U01 AI151814-01

M. Kariuki Njenga, DVM. PhD, Washington State University, Pullman
Center for Research in Emerging Infectious Diseases East and Central Africa (CREID-ECA)
East and Central Africa; 1 U01 AI151799-01

Anavaj Sakuntabhai, MD, PhD, Institute Pasteur, Paris
Pasteur International Center for Research on Emerging Infectious Diseases (PICREID)
West and Central Africa and Southeast Asia; 1 U01 AI151758-01

Nikos Vasilikis, PhD, Texas Medical Branch, Galveston
Coordinating research on emerging arboviral researches, incorporating Neotropics (CREATION-NEO)
Central and South America; 1 U01 AI151807-01

Wesley C. Van Voorhis, MD, Ph.D., University of Washington, Seattle
United World Antiviral Research Network (UWARN)
South America, West and South Africa, Middle East and Asia; 1 U01 AI151698-01

David Wang, PhD, Washington University School of Medicine, St. Louis
Center for Research in Emerging Infectious Disease-Epidemiology, Surveillance, Pathogenesis (Creed-ESP)
Asia, East Africa; 1 U01 AI151810-01

Scott C. Weaver, PhD, University of Texas Medical Branch, Galveston
West African Center for Infectious Infectious Diseases (WAC-EID)
West Africa; 1 U01 AI151801-01

NIAID supports and supports research at the NIH, across the United States, and worldwide – to study the causes of infectious and immune-mediated diseases, and to develop better tools to prevent, diagnose and treat these diseases for. News releases, fact sheets and other NIAID related material are available on the NIAID website.

About National Institutes of Health (NIH):The NIH, the nation’s medical research agency, consists of 27 institutes and centers and is a component of the US Department of Health and Human Services. The NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit

NIH… Turning Discovery into Health®



Leave a Reply

Your email address will not be published.